Breaking Down Liaoning Cheng Da Co., Ltd. Financial Health: Key Insights for Investors

Founded in 1991 and headquartered in Dalian, Liaoning Cheng Da Co., Ltd. (listed as 600739 on the Shanghai Stock Exchange) has grown into a diversified conglomerate spanning biopharmaceuticals, financial investments, supply chain management and energy development, backed by a registered capital of about 1.53 billion yuan and, as of late 2025, a market capitalization of 18.71 billion yuan with 11.29 billion yuan in revenue for fiscal 2024 and a workforce exceeding 3,300 - a profile that brings weight to its pledges to 'create a harmonious century-old Chengda,' 'make employees more prosperous,' 'create more wealth for shareholders,' and 'contribute gratitude to society'; readers will find how those mission and vision statements translate into measurable strategies, and how core values of honesty, integrity, benevolence and harmony guide operational decisions across Northeast China's strategic economic corridor and beyond, shaping stakeholder returns, employee welfare and community impact.

Liaoning Cheng Da Co., Ltd. (600739.SS) - Intro

• Core sectors: Biopharmaceuticals, Financial Investments, Supply Chain Management, Energy Development
• Headquarters: Dalian, Liaoning Province
• Listing: Shanghai Stock Exchange - 600739.SS
• Employees: >3,300 (company-wide)

• Deliver high-quality healthcare products and services by advancing biopharmaceutical R&D and manufacturing capabilities.
• Create long-term shareholder value through disciplined investments and diversified revenue streams across finance, supply chain, and energy.
• Support regional economic development in Northeast China while expanding access to global markets.

• Become a leading integrated industrial and investment group recognized for innovation in biopharma and sustainable energy solutions.
• Build resilient supply chains and financial platforms that catalyze growth for partners and communities.
• Achieve steady, sustainable growth targeting balanced contributions from pharmaceutical operations and investment/energy businesses.

• Integrity: Transparent governance and compliance aligned with SSE listing responsibilities.
• Innovation: Continuous R&D investment in biopharmaceuticals to drive product pipeline expansion.
• Prudence: Risk-aware capital allocation across investments to protect and grow shareholder equity.
• Collaboration: Partnership-driven supply chain solutions and cross-sector synergies to optimize operational efficiency.
• Sustainability: Commitment to environmentally responsible energy projects and social value creation in Northeast China.

• Revenue diversification: Maintain and grow multi-sector revenue streams-FY2024 baseline ¥11.29B.
• R&D intensity: Increase biopharma R&D spend as a percentage of revenue to expand proprietary pipelines.
• Return metrics: Target improvements in ROE and net profit margins through operational optimization and investment returns.
• Market positioning: Leverage Dalian hub to increase export share and cross-border partnerships.

Liaoning Cheng Da Co., Ltd. (600739.SS) - Overview

Mission statement: "Create a harmonious century-old Chengda, make employees more prosperous, create more wealth for shareholders, contribute gratitude to society, and contribute our modest efforts to the country." This mission encapsulates long-term sustainability, stakeholder prosperity, and social responsibility as guiding principles for Liaoning Cheng Da Co., Ltd. (600739.SS).

• Long-term sustainability: commitment to building a resilient, century-lasting enterprise through diversified operations and prudent capital allocation.
• Employee well-being: policies and programs aimed at improving compensation, training, and workplace safety to foster a productive and loyal workforce.
• Shareholder value: strategic focus on steady returns, transparent governance, and disciplined investments to enhance equity value.
• Societal contribution: targeted philanthropy, local community investments, and alignment with national development priorities.

How the mission translates into measurable objectives:

• Corporate governance: alignment of board oversight, risk controls, and investor communication to sustain credibility in public markets (stock code 600739.SS).
• Operational discipline: balancing cash preservation with selective capital expenditure to support core businesses and shareholder distributions.
• Reporting transparency: increasingly standardized disclosures to reflect employee, environmental, and community impacts.

Key strategic levers used to pursue the mission and vision include talent development programs, dividend and capital-allocation policies, targeted reinvestment into core operations, and deliberate CSR initiatives tailored to regional needs. For an investor-focused profile and further detail on ownership and buying patterns see: Exploring Liaoning Cheng Da Co., Ltd. Investor Profile: Who's Buying and Why?

Liaoning Cheng Da Co., Ltd. (600739.SS) - Mission Statement

• Mission: Build a sustainable, resilient enterprise that improves employee prosperity, delivers steady returns to shareholders, and contributes to societal and national development.
• Core focus: Financial discipline, employee well-being, stakeholder transparency, and community engagement.

• 'Make employees more prosperous' - prioritize compensation, training, and career progression to reduce turnover and raise productivity.
• 'Create more wealth for shareholders' - pursue stable earnings growth, disciplined capital allocation, and dividend policies that balance reinvestment with returns.
• 'Contributing gratitude to society' - scale charitable programs, local employment, and environmental initiatives.
• 'Contribute our modest efforts to the country' - align projects with national industrial and social priorities (regional development, employment, infrastructure support).

• Target annual revenue growth: ~5%-8% year-over-year (medium-term).
• Target return on equity (ROE): mid-single digits improving to high-single digits within three years.
• Employee welfare: annual average compensation increase target ~6%-8%; training hours per employee target 40+ hours/year.
• Dividend policy: maintain a stable payout ratio while funding strategic capex and reserves.
• CSR commitment: increase community investment by >10% year-over-year in priority regions.

• People-first: structured wage increases, expanded benefits, and formalized talent pipelines with apprenticeships and internal mobility.
• Prudent growth: capital allocation framework prioritizing ROI > cost of capital, selective M&A, and disciplined capex.
• Shareholder alignment: clearer disclosure cadence, dividend consistency, and investor engagement forums.
• Community & national contribution: targeted local procurement, vocational training initiatives, and measured environmental investments (energy-efficiency upgrades and emissions controls).

• Board oversight aligned to long-term vision with measurable scorecards for employee welfare, shareholder returns, and CSR metrics.
• Annual targets reviewed publicly in investor materials; internal KPIs tied to executive compensation.

Liaoning Cheng Da Co., Ltd. (600739.SS) - Vision Statement

• Honesty and integrity: commit to transparent reporting, regulatory compliance, and anti-corruption measures to protect shareholder value and corporate reputation.
• Benevolence: prioritize employee welfare, community support programs, and responsible supply-chain practices.
• Harmony: cultivate cooperative relationships with regulators, partners, and local communities to sustain stable operating environments.

• Procurement & partners: supplier due diligence and credit terms adjusted to reflect ethical standards and long-term relationships.
• Employee relations: policies to improve training, workplace safety, and retention aligned with benevolence and harmony principles.
• Investor communications: timely disclosures and adherence to listing regulations to embody honesty and integrity.